Antiviral treatment for flu and public health policy

Vaccinations against influenza are recommended by the World Health Organization for those at high risk. The Influenza vaccine is effective against three or four types of influenza. Outbreaks of influenza occur every year and typically reach epidemic levels at some part of the season. Influenza viruses are constantly changing; they can change from one season to the next and can even change within the course of one flu season. Resistance of influenza A viruses to antiviral drugs can occur spontaneously or emerge during the course of antiviral treatment or antiviral exposure. Antiviral medications currently recommended include oseltamivir (Tamiflu®) and zanamivir (Relenza®). The vast majority of currently circulating influenza viruses is sensitive to these medications. Getting a yearly seasonal flu vaccination is the first and most important step in preventing the flu. The vaccine protects against an influenza A (H1N1) virus, an influenza A (H3N2) virus, and one or two influenza B viruses (depending on the vaccine). CDC recommends that everyone 6 months of age and older get vaccinated each year. Viral infections of the respiratory tract impose a high burden on society. In the last half of the 20th century, efforts to prevent or minimize their impact centred on the use of influenza vaccines. Each year enormous effort goes into producing that year's vaccine and delivering it to appropriate sections of the population. 

  • Effectiveness of antivirals
  • Novel antiviral agents in advanced development
  • Antiviral therapeutics and advancement in antiviral drug delivery
  • Novel antiviral therapies for influenza and other respiratory viruses

Related Conference of Antiviral treatment for flu and public health policy

September 23-24, 2019

11th Euro-Global Conference on Infectious Diseases

London, UK

Venue: Park Inn by Radisson Hotel & Conference Centre London Heathrow
September 23-24, 2019

8th International Conference on Tropical Medicine and Infectious Diseases

| ANA Crowne Plaza, Narita | Tokyo, Japan
October 07-08, 2019

5th Annual Congress on Infectious Diseases

Frankfurt, Germany
October 21-22, 2019

15th World Congress on Infection Prevention and Control

ZURICH | SWITZERLAND

Venue: Mövenpick Hotel Zürich Airport
November 25-26, 2019

2nd World Congress on Rare Diseases

Dubai, UAE
January 27-28, 2020

3rd Global Experts Meeting on Infectious Diseases

| Bangkok, Thailand
Feb 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany
March 11-12, 2020

8th International Conference on HIV AIDS STD & STIs

Barcelona, Spain
May 18-19, 2020

7th Global Congress on Rare Diseases & Orphan Drug

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
December 06-07, 2021

3rd World Congress on Rare Diseases

Dubai, UAE

Antiviral treatment for flu and public health policy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in